JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258673

Human SLC25A22 (GC-1) knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

SLC25A22 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 3 and 8 bp deletion in exon 3.

View Alternative Names

GC-1, GHC1_HUMAN, Glutamate/H(+) symporter 1, Mitochondrial glutamate carrier 1, SLC25A22, Solute carrier family 25 member 22

2 Images
Sanger Sequencing - Human SLC25A22 (GC-1) knockout HEK-293T cell lysate (AB258673)
  • Sanger seq

Unknown

Sanger Sequencing - Human SLC25A22 (GC-1) knockout HEK-293T cell lysate (AB258673)

Allele-1 : 8 bp deletion in exon 3

Sanger Sequencing - Human SLC25A22 (GC-1) knockout HEK-293T cell lysate (AB258673)
  • Sanger seq

Unknown

Sanger Sequencing - Human SLC25A22 (GC-1) knockout HEK-293T cell lysate (AB258673)

Allele-2 : 1 bp insertion in exon 3

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 3 and 8 bp deletion in exon 3.

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258673-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human SLC25A22 knockout HEK293T cell lysate", "number":"AB258673-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB258673-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
SLC25A22
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

GC-1 also known as guanylate cyclase 1 is an enzyme with an approximate molecular mass of 82 kDa. It functions mechanically by converting GTP to cGMP a critical second messenger in various cellular processes. GC-1 is expressed in a range of tissues including the brain and retina where it plays important roles in visual and neural functions. Its distribution indicates its involvement in both sensory perception and broader neurological activities.
Biological function summary

GC-1 plays an important role in the signal transduction pathways involving nitric oxide as part of a complex with protein partners. As a subunit of the soluble guanylate cyclase (sGC) complex it helps mediate the effects of nitric oxide by regulating cGMP levels. This activity is essential for promoting vasodilation and blood flow which is observed in the cardiovascular system. The GC-1 complex translates extracellular signals to intracellular responses affecting various physiological processes.

Pathways

GC-1 is a critical component in the nitric oxide signaling pathway where it facilitates communication between nitric oxide and cGMP-dependent pathways. It interacts closely with proteins such as endothelial nitric oxide synthase (eNOS) and is directly involved in the pathway regulating vascular tone and blood pressure. Additionally GC-1 is part of the phototransduction pathway in retinal cells influencing the conversion of light into electrical signals through its production of cGMP.

GC-1 has significant implications in cardiovascular diseases and certain eye disorders. For cardiovascular diseases GC-1 contributes to conditions related to hypertension and heart failure as it affects the nitric oxide-cGMP pathway's ability to mediate vascular relaxation. In the realm of eye disorders particularly retinitis pigmentosa impaired GC-1 function affects photoreceptor cells and visual signal transduction. GC-1's activity is linked to proteins like phosphodiesterase 6 (PDE6) which further highlights its role in maintaining visual acuity and retinal health.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com